Trials of SCS and peripheral nerve stimulation typically include a neurostimulation trial phase 31 and there is an increasing trend for trials of DBS to include a neurostimulation trial phase as new applications are investigated. 32 Specifically, in the NICE technology appraisal guidance for SCS for patients with chronic pain of neuropathic or ischaemic origin, 29 NICE recommends that only patients who have a successful trial phase should undergo permanent SCS device implantation.
← all excerpts
Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension.
1
—
—